Products for Research Use Only
RegisterLogin

Rislenemdaz

CAT: 0804-HY-106441A-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-106441A-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Rislenemdaz (CERC-301) is an orally bioavailable and selective N-methyl-D-aspartate (NMDA) receptor subunit 2B (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM, respectively.
CAS Number
808732-98-1
Product Name Alternative
MK-0657; CERC-301
UNSPSC
12352005
Target
IGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/Rislenemdaz.html
Purity
99.86
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(N1C[C@@H](F)[C@@H](CNC2=NC=CC=N2)CC1)OCC3=CC=C(C)C=C3
Molecular Formula
C19H23FN4O2
Molecular Weight
358.41
References & Citations
[1]Rachel Garner, et al. Preclinical pharmacology and pharmacokinetics of CERC‐301, a GluN2B‐selective N‐methyl‐D‐aspartate receptor antagonist. Pharmacol Res Perspect. 2015 Dec; 3 (6) : e00198.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
NMDA Receptor

Chemical Information

Rislenemdaz

Mk 0657 has been used in trials studying the treatment of Major Depressive Disorder.

CAS Number808732-98-1
PubChem CID11394238
IUPAC Name(4-methylphenyl)methyl (3S,4R)-3-fluoro-4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate
Molecular FormulaC19H23FN4O2
Molecular Weight358.4
XLogP3.1
Topological Polar Surface Area67.4
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count6
Heavy Atom Count26
Formal Charge0
Complexity439
SMILES
CC1=CC=C(C=C1)COC(=O)N2CC[C@@H]([C@@H](C2)F)CNC3=NC=CC=N3
InChI
InChI=1S/C19H23FN4O2/c1-14-3-5-15(6-4-14)13-26-19(25)24-10-7-16(17(20)12-24)11-23-18-21-8-2-9-22-18/h2-6,8-9,16-17H,7,10-13H2,1H3,(H,21,22,23)/t16-,17-/m1/s1
InChIKey
RECBFDWSXWAXHY-IAGOWNOFSA-N
Chemical Structure
2D Structure
2D structure of Rislenemdaz
CAS: 808732-98-1
CID: 11394238
Formula: C19H23FN4O2
MW: 358.4
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight358.4
XLogP33.1
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count6
Exact Mass358.18050415
Monoisotopic Mass358.18050415
Topological Polar Surface Area67.4 Ų
Heavy Atom Count26
Formal Charge0
Complexity439
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Alternative Products

CatalogName
MBS5753827Rislenemdaz
A21907-10Rislenemdaz 10mg
A21907-5Rislenemdaz 5mg
M16024Rislenemdaz hydrochloride
A21907-50Rislenemdaz 50mg
MBS3602971Rislenemdaz mesylate
A21907-200Rislenemdaz 200mg
A21907-100Rislenemdaz 100mg
A21907-25Rislenemdaz 25mg
A21907-1Rislenemdaz 1mg

Popular Products